Physician profile
Karen B Yoder
NPI 1982656864
$2,181.48
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $746 · 2022: $1,386 · 2023: $22.79 · 2024: $26.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $629.45 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $374.33 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $164.66 | 2021-2022 | |
| Celgene Corporation | $157.50 | 2021-2022 | |
| Pfizer INC. | $152.42 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $139.19 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $86.38 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $60.40 | 2021-2022 | |
| Ardelyx, INC. | $56.60 | 2022 | |
| Ethicon US, LLC | $52.97 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $47.29 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $44.72 | 2022 | |
| Ferring Pharmaceuticals INC. | $34.38 | 2021-2022 | |
| Alfasigma USA, INC. | $33.75 | 2021-2022 | |
| Gilead Sciences, INC. | $28.69 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $28.08 | 2021 | |
| Axonics, INC. | $26.83 | 2024 | Axonics |
| Amgen INC. | $24.64 | 2021 | |
| Braintree Laboratories, INC. | $23.08 | 2022 | |
| Qol Medical, LLC | $16.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.